Flavio Arienti

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by geneMAGE-3 and presented by HLA-A1

Marie Marchand, Nicolas van Baren, P. Weynants et al. · International Journal of Cancer · 1999 · 786 citations

Subcutaneous Injections, Immunology, Immunoediting +20

Vaccination of Metastatic Melanoma Patients With Autologous Tumor-Derived Heat Shock Protein gp96-Peptide Complexes: Clinical and Immunologic Findings

Filiberto Belli, Alessandro Testori, Licia Rivoltini et al. · Journal of Clinical Oncology · 2002 · 385 citations

Expression of <i>MAGE</i> genes in primary and metastatic cutaneous melanoma

Francis Brasseur, Donata Rimoldi, Danielle Líénard et al. · International Journal of Cancer · 1995 · 285 citations

Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma

Veronica Huber, Viviana Vallacchi, Viktor Fleming et al. · Journal of Clinical Investigation · 2018 · 245 citations · Full text

Cancer Immunosurveillance, Mdsc Features, Mdsc Activity +14

beta2-Microglobulin mutations, HLA class I antigen loss, and tumor progression in melanoma.

Daniel J. Hicklin, Z Wang, Flavio Arienti et al. · Journal of Clinical Investigation · 1998 · 197 citations · Full text

Immunology, Tumor Progression, Pathology +17